To the full analysis
Agenus stock: growth
AGENAgenus reported $114.2M in revenue for fiscal 2025, up 10.4% on the prior year, up 5.3% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
30.8%
per year from 2006 to 2025, per share 21.8%
Earnings (Annual rate)
no data
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 5.3% | 16.5% | 30.8% |
| Revenue per share | −17.8% | −4.9% | 21.8% |
| Earnings | no data | no data | no data |
| Earnings per share | no data | no data | no data |
| Free cash flow | no data | no data | no data |
| Free cash flow per share | no data | no data | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $692.14K | −$51.88M | −$45.27M |
| 2007 | $5.55M | −$36.8M | −$26.7M |
| 2008 | $2.65M | −$28.7M | −$29.12M |
| 2009 | $3.33M | −$30.32M | −$24.44M |
| 2010 | $3.36M | −$21.91M | −$14.89M |
| 2011 | $2.76M | −$23.28M | −$16.3M |
| 2012 | $15.96M | −$11.33M | $909.16K |
| 2013 | $3.05M | −$30.07M | −$20.35M |
| 2014 | $6.98M | −$42.49M | −$41.05M |
| 2015 | $24.82M | −$87.88M | −$50.77M |
| 2016 | $22.57M | −$127M | −$92.48M |
| 2017 | $42.88M | −$120.69M | −$97.35M |
| 2018 | $36.78M | −$159.69M | −$134.69M |
| 2019 | $150.05M | −$107.66M | −$23.34M |
| 2020 | $88.17M | −$180.91M | −$142.56M |
| 2021 | $295.67M | −$23.93M | −$23.67M |
| 2022 | $98.02M | −$220.07M | −$228.44M |
| 2023 | $156.31M | −$245.76M | −$234.16M |
| 2024 | $103.46M | −$227.21M | −$158.89M |
| 2025 | $114.2M | $115K | −$158.89M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral since 13 Nov 2026, previously Weak
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.